Funding for this research was provided by:
The Korea Health Industry Development Institute (HB16C0026)
Received: 19 April 2017
Accepted: 3 February 2018
First Online: 20 February 2018
Ethics approval and consent to participate
: The Institutional Review Boards (IRBs) of DongShin University Gwangju Oriental Hospital, DongShin University Mokpo Oriental Hospital, and KyungHee Korean Medicine Hospital have all approved the study. The purpose and potential risks of this clinical trial will be fully explained to the participants and their families. All participants will be asked to provide written informed consent before participating in the study. This trial was registered with cris.nih.go.kr (registration number: KCT0002257) on 27 February 2017, and it has been approved by the Ministry of Food and Drug Safety (Medical Device Clinical Trial Plan Approval #737).
: Written informed consent for the publication of their individual details and accompanying images will be obtained from the participants in the trial. The consent form is held by the authors and is available for review by the Editor-in-Chief of this Journal.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.